We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI-Based Staining Technique as Accurate as Traditional Histopathology in Assessing Breast Cancer Biomarker

By LabMedica International staff writers
Posted on 28 Oct 2022

Breast cancer is one the leading causes of cancer death among women globally. More...

Upon breast cancer diagnosis, the testing of HER2 – a protein that promotes cancer cell growth, is routinely carried out to help assess the cancer prognosis and make HER2-directed treatment plans. A standard HER2 test procedure includes taking the breast biopsy, preparing the tissue specimen into thin microscopic slides, staining/dying the slides with specific chemical reagents that highlight the HER2 proteins, and inspecting the stained slides under an optical microscope to provide the pathological report. However, this standard HER2 staining procedure suffers from high costs and long turn-around time as the staining process requires laborious sample treatment steps (typically ~24 hours) performed by experts in a dedicated laboratory facility. Researchers have now developed a computational staining approach powered by deep learning, which performs the HER2 staining without requiring any chemicals.

The research team at UCLA (Los Angeles, CA, USA) captured the autofluorescence information of the unstained breast tissue, which is naturally emitted by biological structures when they absorb light. They further trained a deep neural network that rapidly transforms these stain-free autofluorescence images into virtual histological images, revealing the accurate color and contrast as if the tissue sections were chemically stained for HER2. This computational staining process takes only a few minutes per sample and does not need expensive facilities or toxic chemicals. Using only a computer, the HER2 staining could be accomplished much faster and cost-effectively, accelerating breast cancer assessments and treatment.

Board-certified pathologists blindly validated this AI-based virtual HER2 staining technique in terms of both its diagnostic value and stain quality. The pathologists confirmed that the deep learning-generated images provide the equivalent diagnostic accuracy for HER2 assessment and have a staining quality comparable to the standard images chemically stained in the laboratory. This deep learning-powered virtual HER2 staining approach eliminates the need for costly, laborious, and time-consuming HER2 staining procedures performed by histology experts and could be extended to staining of other cancer-related biomarkers to accelerate the traditional histopathology and diagnostic workflow in clinical settings.

Related Links:
UCLA


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Staining Management Software
DakoLink
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.